Singapore: The Indian Health Ministry has said that the regulatory authorities in the country have so far inspected 577 ...
Singapore: South African-based Synexus' clinical research centers Stanza, Watermeyer and Nyeleti will join Pfizer's worl...
According to market report published by Persistence Market Research "Global Market Study on Clinical Trial Management Sy...
Singapore: ERT, a US-based service provider to biopharmaceutical organizations, medical device companies and contract re...
Singapore: Clinical trials were once undertaken largely in the West. However many Asian countries are now emerging as to...
Singapore: NextDocs, the global leader in compliance solutions for regulated industries, announced that it has expanded ...
Singapore: In a bid to race ahead to be among the top three Asian clinical research organizations in the next five years...
OmniComm Systems Inc., a provider of clinical data management technology, announces the selection of the company's Proma...
Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and m...
Singapore: WuXi PharmaTech's Laboratory Testing Division (LTD) has partnered with Lee Pharma as an exclusive supplier of...
Singapore: QPS Taiwan, a global preclinical toxicology services provider, has been selected to deploy Pristima Suite, w...
Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexava...
Singapore: Researchers have begun enrolling participants in to a multicenter international clinical trial to test whethe...
Singapore: China's BeiGene, a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and im...
Tokyo: Intercept Pharmaceuticals Inc has announced the results of a 72-week phase II dose ranging trial of obeticholic a...
Pharmaceutical Product Development(PPD) and CISYS LifeSciences has announced PPD's implementation of Sequence WebEAS, a ...
Singapore: QPS Holdings, a leading full-service clinical research organization, announced the launch of its QPS Qualiti...
Singapore: Cellmid has completed its first in-life diabetic nephropathy study with the company's anti-midkine antibodie...
